Article Details

Roche to present data for fenebrutinib from Phase II FENopta OLE study - TipRanks.com

Retrieved on: 2024-09-04 16:29:06

Tags for this article:

Click the tags to see associated articles and topics

Roche to present data for fenebrutinib from Phase II FENopta OLE study - TipRanks.com. View article details on hiswai:

Excerpt

Roche will present new 48-week data for the investigational Bruton's tyrosine kinase, BTK, inhibitor fenebrutinib from the Phase II FENopta ...

Article found on: www.tipranks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo